Cargando…
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
BACKGROUND: The global increase in the burden of multidrug-resistant tuberculosis (MDR-TB) underscores an urgent need for data on factors involved in generation and spread of TB drug resistance. We performed molecular analyses on a representative sample of Mycobacterium tuberculosis (MTB) isolates....
Autores principales: | Ezati, Nicholas, Lukoye, Deus, Wampande, Eddie M, Musisi, Kenneth, Kasule, George W, Cobelens, Frank GJ, Kateete, David P, Joloba, Moses L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367914/ https://www.ncbi.nlm.nih.gov/pubmed/25523472 http://dx.doi.org/10.1186/s12879-014-0703-0 |
Ejemplares similares
-
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda
por: Kigozi, Edgar, et al.
Publicado: (2018) -
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016) -
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
por: Kasule, George W., et al.
Publicado: (2016) -
Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection
por: Lukoye, Deus, et al.
Publicado: (2011) -
Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda
por: Wampande, Eddie M., et al.
Publicado: (2019)